Postural Orthostatic Tachycardia Syndrome (POTS): A critical assessment.

Postural Orthostatic Tachycardia Syndrome (POTS): A critical assessment.
复制标题

DOI:
10.1016/j.pcad.2020.03.010
复制
发表时间:
2020-05
影响因子:
9.1
通讯作者:
Benditt, David G.
Benditt, David G.
中科院分区:
医学2区
文献类型:
--
作者:
Olshansky, Brian;Cannom, David;Fedorowski, Artur;Stewart, Julian;Gibbons, Christopher;Sutton, Richard;Shen, Win-Kuang;Muldowney, James;Chung, Tae Hwan;Feigofsky, Suzy;Nayak, Hemal;Calkins, Hugh;Benditt, David G.

文献摘要

参考文献

被引文献

相似文献

虽然体位性心动过速综合征(POTS)的诊断标准已经制定,但没有一套标准被普遍接受。此外,目前用于确定患有这种疾病的个人的标准存在差距。生理学发现的可重复性、症状与生理学发现的关系、仅存在症状而没有任何生理学发现以及对各种干预措施的反应混淆而不是澄清了这种情况。由于许多疾病实体可能与POTS混淆,因此确定这种综合征是什么变得至关重要。什么似乎是POTS可能是一个潜在的条件,需要特定的治疗。POTS不是简单的直立性不耐受和症状或间歇性直立性心动过速,而是需要随着时间的推移和可重复性来表征该综合征。在这里,我们解决关键问题的病理生理学和诊断POTS在试图达到一个合理的方法来分类的综合征,希望它可以帮助更好地识别个人和更好地理解的治疗方法。
Although diagnostic criteria have been developed characterizing postural orthostatic tachycardia syndrome (POTS), no single set of criteria is universally accepted. Furthermore, there are gaps in the present criteria used to identify individuals who have this condition. The reproducibility of the physiological findings, the relationship of symptoms to physiological findings, the presence of symptoms alone without any physiological findings and the response to various interventions confuse rather than clarify this condition. As many disease entities can be confused with POTS, it becomes critical to identify what this syndrome is. What appears to be POTS may be an underlying condition that requires specific therapy. POTS is not simply orthostatic intolerance and symptoms or intermittent orthostatic tachycardia but the syndrome needs to be characterized over time and with reproducibility. Here we address critical issues regarding the pathophysiology and diagnosis of POTS in an attempt to arrive at a rational approach to categorize the syndrome with the hope that it may help both better identify individuals and better understand approaches to therapy.
DOI: 10.1093/europace/euw154
发表时间: 2017-07-01
期刊: EUROPACE
影响因子: 6.1
作者:
Fedorowski, Artur;Li, Hongliang;Kem, David C.
通讯作者: Kem, David C.
DOI: 10.1161/01.hyp.0000185462.08685.da
发表时间: 2005-11-01
期刊: HYPERTENSION
影响因子: 8.3
作者:
Garland, EM;Winker, R;Robertson, D
通讯作者: Robertson, D
DOI: 10.1016/j.jadohealth.2017.08.004
发表时间: 2017-11-01
影响因子: 7.6
作者:
Arana, Jorge;Mba-Jonas, Adamma;Cano, Maria
通讯作者: Cano, Maria
DOI: 10.1161/hypertensionaha.111.172262
发表时间: 2011-08-01
期刊: HYPERTENSION
影响因子: 8.3
作者:
Fu, Qi;VanGundy, Tiffany B.;Levine, Benjamin D.
通讯作者: Levine, Benjamin D.
DOI: 10.1007/s10286-010-0091-5
发表时间: 2011-04-01
影响因子: 5.8
作者:
Galbreath, M. Melyn;Shibata, Shigeki;Levine, Benjamin D.
通讯作者: Levine, Benjamin D.